CHATROOM

4 Reasons Why Susan Boyle Is & Is Not Like A Penny Stock…

April 19, 2009 at 9:45 am
by Timothy Sykes

Watch these 7 free video lessons on how I became a millionaire

As I outline in my PennyStocking DVDs and THIS FREE EBOOK, a Supernova chart pattern, the ones that’s made me millions of dollars over the past decade.

Like Ashley Dupre, aka Sptizer’s girl, Susan Boyle shares some qualities with Supernovas, but she also differs a bit too and that’s why when I make the comparison, I wouldn’t short her….just yet

1. SIMILAR: massive massive hype and press due to the novelty of the idea and a dominating coordinated PR effort by Simon Cowell’s companies (he would be the best damn penny stock promoter ever!)

2. DISSIMILAR: S.B. has the unique story and enough talent that will likely make her a star…question is for how long…remember that other opera dude Paul Potts who Cowell made believe was a cell phone salesman shot to fame and now has pretty much faded…like most singing contest winning stars (it’s all marketing!)

3. SIMILAR: Like Paul Potts, Susan Boyle isn’t some undiscovered sensation…she had a 1999 album…yup…this time she hit it big with marketingggggg! Most penny stocks rise due to hype and manipulation, don’t hate on it, love it!!!!

4. OK, here’s the viral video of her singing, she has a great voice, but the key is her look and people’s expectations…kinda like a homeless hedge fund manager

I’m 100% sure, some kind of news will break over the next few days and weeks that lessens her star–no, I’m not a cynic, I just know how hype and manipulation works–but for now Susan enjoy it, your reaping the rewards of partnering with Simon Cowell, the world’s #1 promoter.

Posted in Breakouts, Celebrities

Tags: ,

No related posts.

  • coen

    The ebook ‘email system’ (still) isnt working, i received some weird vcf file.

  • coen

    The ebook ‘email system’ (still) isnt working, i received some weird vcf file.

  • JIM

    I want to thank you for SHORTING DELCATH SYSTEMS (DCTH)

    Your SHORT CALL on DELCATH SYSTEMS is 100% –> WRONG

    And I am going to enjoy your Money !!!

    Here is WHY :

    The CEO of DCTH, Richard Taney, gave an investor presentation in October (in Boston) that stated that he expects DCTH to generate IMMENSE annual revenues based on the company’s ability to capture 5% to 20% market share of the annual liver cancer market of just the United States:

    DCTH’s CEO forecasts the following potential Annual Revenues based on the following market share assumptions:

    5% market share —-> $241 million in Annual Revenue
    10% market share —-> $482 million in Annual Revenue
    15% market share —-> $724 million in Annual Revenue
    20% market share —-> $965 million in Annual Revenue

    ==================================================
    DCTH only has —-> 25 Million Shares Outstanding
    ==================================================

    Assuming 80% Profit Margins DCTH could earn:

    5% market share —> $ 72 Million in Net Profits Annually –>
    EPS of $7+ a share
    10% market share —-> $144 Million in Net Profits Annually –>
    EPS of $15+ a share
    15% market share —-> $216 Million in Net Profits Annually –>
    EPS of $23 + a share
    20% market share —-> $290 Million in Net Profits Annually –>
    EPS of $30 + a share

    DCTH is also entitled to the use of a very valuable Net Operating Loss Carryforward of more than –> $90 Million Dollars.

    Any mention of an FDA Approval for DCTH’s technology …. Would be like setting a lit match to Gasoline

    Here are 2 HINTS for you – your followers & ur —> SHORT RECOMMENDATION:

    1) These X-Rays are published in “The Journal of Clinical Oncology”

    These are the XRAYS of a DELCATH PATIENT who EXPERIENCED a —> COMPLETE REMISSION from LIVER CANCER
    LINK:
    http://jco.ascopubs.org/content/vol23/issue15/images/large/zlj0150522160003.jpeg

    2) This was DCTH —> Featured on ABC NIGHTLY NEWS w/ CHARLES GIBSON
    LINK: DCTH on ABC NEWS in FEBRUARY 2009
    http://abcnews.go.com/Video/playerIndex?id=6807281

    Best of Luck to You —-> You are Going to Need IT !!!!

  • JIM

    I want to thank you for SHORTING DELCATH SYSTEMS (DCTH)

    Your SHORT CALL on DELCATH SYSTEMS is 100% –> WRONG

    And I am going to enjoy your Money !!!

    Here is WHY :

    The CEO of DCTH, Richard Taney, gave an investor presentation in October (in Boston) that stated that he expects DCTH to generate IMMENSE annual revenues based on the company’s ability to capture 5% to 20% market share of the annual liver cancer market of just the United States:

    DCTH’s CEO forecasts the following potential Annual Revenues based on the following market share assumptions:

    5% market share —-> $241 million in Annual Revenue
    10% market share —-> $482 million in Annual Revenue
    15% market share —-> $724 million in Annual Revenue
    20% market share —-> $965 million in Annual Revenue

    ==================================================
    DCTH only has —-> 25 Million Shares Outstanding
    ==================================================

    Assuming 80% Profit Margins DCTH could earn:

    5% market share —> $ 72 Million in Net Profits Annually –>
    EPS of $7+ a share
    10% market share —-> $144 Million in Net Profits Annually –>
    EPS of $15+ a share
    15% market share —-> $216 Million in Net Profits Annually –>
    EPS of $23 + a share
    20% market share —-> $290 Million in Net Profits Annually –>
    EPS of $30 + a share

    DCTH is also entitled to the use of a very valuable Net Operating Loss Carryforward of more than –> $90 Million Dollars.

    Any mention of an FDA Approval for DCTH’s technology …. Would be like setting a lit match to Gasoline

    Here are 2 HINTS for you – your followers & ur —> SHORT RECOMMENDATION:

    1) These X-Rays are published in “The Journal of Clinical Oncology”

    These are the XRAYS of a DELCATH PATIENT who EXPERIENCED a —> COMPLETE REMISSION from LIVER CANCER
    LINK:
    http://jco.ascopubs.org/content/vol23/issue15/images/large/zlj0150522160003.jpeg

    2) This was DCTH —> Featured on ABC NIGHTLY NEWS w/ CHARLES GIBSON
    LINK: DCTH on ABC NEWS in FEBRUARY 2009
    http://abcnews.go.com/Video/playerIndex?id=6807281

    Best of Luck to You —-> You are Going to Need IT !!!!

  • http://test.timothysykes.com Timothy Sykes

    DCTH is a piece of crap just like that guy…but i havent shorted it yet as crap rises before going splat

  • http://test.timothysykes.com Timothy Sykes

    DCTH is a piece of crap just like that guy…but i havent shorted it yet as crap rises before going splat

  • http://www.awalkinmyshoes.com Melody

    lol..interesting analogy..I wonder if her future album will sell better than william hung’s

  • http://www.awalkinmyshoes.com Melody

    lol..interesting analogy..I wonder if her future album will sell better than william hung’s

  • Buddy

    Sure… a piece of crap that has a phase III headed by the NCI (with 11 other prominent centers on board) for metastatic melanoma to the liver, (along with a 4 phase II trials) that should be submitting a NDA before years end.

    Yes there is much “crap” out there, but it takes more than just looking at a chart to find them. But hey PLEASE short DCTH. Just get out before they announce 75% enrollment and an accelerated time line to NDA submission.

    Good luck.

  • Buddy

    Sure… a piece of crap that has a phase III headed by the NCI (with 11 other prominent centers on board) for metastatic melanoma to the liver, (along with a 4 phase II trials) that should be submitting a NDA before years end.

    Yes there is much “crap” out there, but it takes more than just looking at a chart to find them. But hey PLEASE short DCTH. Just get out before they announce 75% enrollment and an accelerated time line to NDA submission.

    Good luck.